FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/063593 [Registered on: 05/03/2024] Trial Registered Prospectively
Last Modified On: 04/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To assess efficacy of steroid as adjuvant added to local anaesthetic in regional technique for pain management in laproscopic inguinal hernia repair- a randomized controlled prospective study 
Scientific Title of Study   To Compare the analgesic efficacy of Ropivacaine versus Ropivacaine with Dexamethasone for Post-operative analgesia in Ultrasound guided TAP ( Transversus Abdominis Plane) block for Laproscopic Inguinal Hernia repair-a randomized doube blind controlled prospective study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rajesh Kumar Harish 
Designation  Consultant 
Affiliation  Fortis Hospital, Mohali 
Address  Department of Anaesthesia,Fortis Hospital, Sahibzada Ajit Singh Nagar, Sector 62, Lamba, Mohali 160062

Chandigarh
CHANDIGARH
160062
India 
Phone  9417661053  
Fax    
Email  hearty2brainy@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rajesh Kumar Harish 
Designation  Consultant 
Affiliation  Fortis Hospital, Mohali 
Address  Department of Anaesthesia, Fortis Hospital, Sahibzada Ajit Singh Nagar, Sector 62, Lamba, Mohali 160062

Chandigarh
CHANDIGARH
160062
India 
Phone  9417661053  
Fax    
Email  hearty2brainy@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Anmol Singla 
Designation  Junior Resident 
Affiliation  Fortis Hospital, Mohali 
Address  Department of Anaesthesia, Fortis Hospital, Sahibzada Ajit Singh Nagar, Sector 62, Lamba, Mohali 160062

Chandigarh
CHANDIGARH
160062
India 
Phone  7889209159  
Fax    
Email  anmolsingla50@gmail.com  
 
Source of Monetary or Material Support  
Fortis hospital,Mohali 
 
Primary Sponsor  
Name  Fortis Hospital, Mohali 
Address  Department of Anaesthesia, Fortis Hospital, Mohali 
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rajesh Kumar Harish  Fortis Hospital  Department of Anaesthesia,Fortis hospital,Sector 62,Sahibzada Ajit Singh Nagar,Mohali
Chandigarh
CHANDIGARH 
9417661053

hearty2brainy@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee,Fortis Hospital,Mohali  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  TAP block with Ropivacaine with Dexamethasone  USG guided TAP block with Ropivacaine with Dexamethasone total volume 20ml + 2 ml in adult patients undergoing Laproscopic Inguinal hernia repair under general anaesthesia and pain will be scored according to VAS scale on 0,2,4,8,12,16,24 hrs 
Comparator Agent  TAP block with Ropivacaine with Normal saline  USG guided TAP block with Ropivacaine with Normal saline total volume 20ml + 2 ml in adult patients undergoing Laproscopic Inguinal hernia repair under general anaesthesia and pain will be scored according to VAS scale on 0,2,4,8,12,16,24 hrs 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Male 
Details  ASA Grade 1 & 2
Patients in age group of 18-65 years posted for laproscopic inguinal hernia surgery
Willing to participate 
 
ExclusionCriteria 
Details  Patient refusal
History of allergy or contraindication to study medicine
ASA Grade 3 & 4
Drug or Alcohol abuse
Surgery converted to open procedure 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
To evaluate the time of First rescue analgesia post-operatively
Evaluate total doses of rescue analgesia in 24 hrs 
VAS scores will be assessed at 0hr,2hr,4hr,8hr,12hr,16hr,24hr
Total dose of rescue analgesia will be assessed in 24 hrs 
 
Secondary Outcome  
Outcome  TimePoints 
Evaluate efficacy of TAP block in providing post-operative analgesia in laproscopic inguinal hernia surgeries
Evaluate safety and adverse effects of TAP block
Assess pain severity using Visual Analogue score(VAS score)
Post-operative opioid consumption 
0hr,2hr,4hr,8hr,16hr,24hr 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   14/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Laproscopic surgeries are commonly performed surgical procedures and these patients require a multi-modal post-operative pain treatment regimen. Regional anaesthesia techniques have shown to decrease consumption as well as its adverse effects.
Transversus Abdominis Plane (TAP) block is a regional anaesthesia technique that has been applied in multi-modal pain regimen in laproscopic and open abdominal surgeries for reduction in pain scores and opioid use,reduced incidence of post operative nausea and vomiting has also been noted.

Dexamethasone is a corticosteroid which has been used here owing to its anti-inflammatory properties and suppressing the synthesis and secretion of various inflammatory mediators has been found to prolong the period of analgesia upto 48 hrs.Use of Perineural Dexamethsaone has been associated with less analgesic consumption and a lower incidence of post-operative nausea and vomiting
 
Close